AdvaMed Statement on CMS’s Proposed Rule for Breakthrough Technology Coverage
AdvaMed, the Medtech Association, released the following statement from President and CEO Scott Whitaker on the recently issued proposed Transitional Coverage for Emerging Technologies (TCET) rule.